medigraphic.com

2017, Number 2

<< Back Next >>

Rev Hosp Jua Mex 2017; 84 (2)

Central myocardial stunning secondary to ischemic cerebrovascular event. Case report

Zamora-Gómez SE, García-Rosas G, Miño-Bernal J, Espino-Franco F

Language: Spanish
References: 20
Page: 93-102
PDF size: 603.5 Kb.


ABSTRACT

Introduction: Neurogenic myocardial stunning (NMS) is a reversible, sudden myocardial dysfunction secondary to acute brain injury due to an imbalance in the functioning of the autonomic nervous system. Its clinical alterations include acute left ventricular failure, metabolic acidosis, increased cardiac enzymes and type B natriuretic peptide, its treatment is oriented to the underlying neurological process with the objective of maximizing the neurological recovery, which will favor the improvement of the cardiac function. Objective: We present the case to review current concepts in the pathophysiology and treatment of this entity. Case report: Woman aged 72 presented to the emergency room with sudden neurological deterioration secondary to cerebrovascular event ischemic, their studies (electrocardiogram, echocardiogram and cardiac biomarkers) documented not symptomatic left ventricular dysfunction, with supportive therapy, has neurological improvement and normalization of cardiac biomarkers. Conclusions: NMS is a poorly recognized entity, which can worsen the patient’s prognosis if it is not recognized.


REFERENCES

  1. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66: 1146-9.

  2. Bolli R. Mechanism of myocardial “stunning”. Circulation 1990; 82(3): 723-38.

  3. Kloner RA, Arimie RB, Kay GL, Cannom D, Matthews R, Bhadari A, et al. Evidence for stunned myocardium in humans: a 2001 update. Coron Artery Dis 2001; 12(5): 349-56.

  4. Murthy SB, Shah S, Venkatasubba RC, Suarez JI, Bershad EM. Clinical characteristics of myocardial stunning in acute stroke. J Clin Neurosci 2014; 21(8): 1279-82.

  5. Dombrowski K, Laskowitz D. Cardiovascular manifestations of neurologic disease. Handb Clin Neurol 2014; 119: 3-17.

  6. Murthy SB, Shah S, Rao CP, Bershap EM, Suarez JI. Neurogenic stunned myocardium following acute subarachnoid hemorrhage: pathophysiology and practical considerations. J Intensive Care Med 2015; 30(6): 318-25.

  7. Ng L, Wang Y, Altaweel L, Athar MK. Neurologic aspects of cardiac emergencies. Crit Care Clin 2014; 30(3): 557-84.

  8. Van Eyk JE, Murphy AM. The role of troponin abnormalities as a cause for stunned myocardium. Coron Artery Dis 2001; 12(5): 343-7.

  9. Papanikolaou J, Makris D, Zakynthinos E. The role of nuclear cardiac imaging in redefining neurogenic stunned myocardium in subarachnoid hemorrhage: a deeper look into the heart. Crit Care 2014; 18(4): 490.

  10. Prunet B, Basely M, D’Aranda M, Cambefort P, Pons F, Cimarelli S, et al. Impairment of cardiac metabolism andsympathetic innervation after aneurysmal subarachnoid hemorrhage: a nuclear medicine imaging study. Crit Care 2014; 18: R131.

  11. Bolli R, Marbán E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 1999; 79(2): 609-34.

  12. Pinnamaneni S, Dutta T, Melcer J, Aronow WS. Neurogenic stress cardiomyopathy associated with subarachnoid hemorrhage. Future Cardiol 2015; 11(1): 77-87.

  13. Mierzewska-Schmidt M, Gawecka A. Neurogenic stunned myocardium — do we consider this diagnosis in patients with acute central nervous system injury and acute heart failure? Anaesthesiology Intensive Ther 2015; 47(2): 175-80.

  14. Magid-Bernstein J, Al-Mufti F, Merkler AE, Merkler AE, Roh D, Patel S, et al. Unexpected rapid improvement and neurogenic stunned myocardium in a patient with acute motor axonal neuropathy: a case report and literature review. J Clin Neuromusc Dis 2016; 17(3): 135-41.

  15. Moriya S, Inamasu J, Oheda M, Hirose Y. Neurogenic stunned myocardium associated with pediatric brain tumor may not be catecholamine-induced. Ann Pediatr Cardiol 2015; 8(3): 240-42.

  16. Malik AN, Gross BA, Rosalind LP, Moses ZB, Du R. Neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2015; 83(6): 880-85.

  17. Ohtsuka T, Hamada M, Kodama K, Sasaki O, Suzuki M, Hara Y, et al. Images in cardiovascular medicine. Neurogenic stunned myocardium. Circulation. 2000; 101(17): 2122-24.

  18. Wybraniec MT, Mizia-Stec K, Krzych Ł. Neurocardiogenic injury in subarachnoid hemorrhage: A wide spectrum of catecholamin-mediated brain-heart interactions. Cardiol J 2014; 21(3): 220-28.

  19. Akutsu Y, Kaneko K, Kodama Y, Li HL, Suyama J, Toshida T, et al. Reversible T-wave inversions and neurogenic myocardial stunning in a patient with recurrent stress-induced cardiomyopathy. Ann Noninvasive Electrocardiol 2014; 19(3): 285-8.

  20. Przyklenk K. Pharmacologic treatment of the stunned myocardium: the concepts and the challenges. Corony Artery Dis 2001; 12(5): 363-9.




2020     |     www.medigraphic.com